Canada Pension Plan Investment Board’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
AI
Canada Pension Plan Investment Board's HAE Position: Q2 2026 in Review
Canada Pension Plan Investment Board sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 17,400 shares — an estimated $981K sold.
Canada Pension Plan Investment Board first reported a position in HAE in Q4 2017 and held it in 8 quarters. The position peaked at $5.75M in Q4 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Canada Pension Plan Investment Board reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
- Canada Pension Plan Investment Board sold 17,400 Haemonetics shares in Q2 2026, an estimated $981K.
- Canada Pension Plan Investment Board first reported a position in Haemonetics in Q4 2017 and held it in 8 quarters.
- Canada Pension Plan Investment Board's Haemonetics position peaked at $5.75M in Q4 2019.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.